Association Of Modified Glasgow Prognostic Score (Mgps) With Survival Outcomes In Patients With Metastatic Renal Cell Carcinoma (Mrcc) Treated With Immune Checkpoint Inhibitors (Cpi)

Jacqueline T Brown,Yuan Liu,Dylan J. Martini,Julie M. Shabto,Elise Hitron,Greta Russler,Sarah Caulfield,Lauren Beth Yantorni,Shreyas S. Joshi,Haydn Kissick,Kenneth Ogan,Bradley Curtis Carthon,Omer Kucuk,Wayne Harris,Viraj A. Master,Mehmet Asim Bilen

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 1|浏览34

暂无评分

摘要

738Background: The current risk models for mRCC were developed for patients treated with targeted therapy. The mGPS incorporates albumin and C-reactive protein and may serve as a composite prognost...

查看译文

关键词

metastatic renal cell carcinoma,renal cell carcinoma,immune checkpoint inhibitors,modified glasgow prognostic score,mgps

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要